The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 22 (5) , 677-682
- https://doi.org/10.1016/0091-3057(85)90512-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Antagonism of the effects of the hallucinogen dom and the purported 5-HT agonist quipazine by 5-HT2 antagonistsEuropean Journal of Pharmacology, 1983
- 5-HT2 receptor blockade to study serotonin-induced pathologyTrends in Pharmacological Sciences, 1983
- Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination proceduresNeuroscience & Biobehavioral Reviews, 1982
- Multiple serotonin receptors: Regional distribution and effect of raphe lesionsEuropean Journal of Pharmacology, 1981
- Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergolinePharmacology Biochemistry and Behavior, 1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated ratsPharmacology Biochemistry and Behavior, 1980
- Naloxone potentiates the disruptive effects of mescaline on operant responding in the ratPharmacology Biochemistry and Behavior, 1980
- Structural relationships in the inhibition of [3H]serotonin binding to rat brain membranes in vitro by 1-phenyl-piperazinesBiochemical Pharmacology, 1980
- An animal behavior model for studying central serotonergic synapsesLife Sciences, 1976